Provided by Tiger Fintech (Singapore) Pte. Ltd.

MaxCyte Inc

2.12
+0.01000.47%
Volume:442.34K
Turnover:934.48K
Market Cap:225.60M
PE:-5.34
High:2.15
Open:2.13
Low:2.07
Close:2.11
Loading ...

MaxCyte Announces CFO’s RSU Vesting and Share Sale

TIPRANKS
·
26 Mar

MaxCyte management to meet with BTIG

TIPRANKS
·
20 Mar

BlackRock Increases Stake in MaxCyte to 7.71%

TIPRANKS
·
19 Mar

BRIEF-Maxcyte Sees 2025 Core Revenue To Grow 8% To 15%

Reuters
·
12 Mar

MaxCyte Inc (MXCT) Q4 2024 Earnings Call Highlights: Strategic Growth Amid Revenue Challenges

GuruFocus.com
·
12 Mar

MaxCyte Inc - FY24 Net Loss $41.1 Mln VS Loss of $37.9 Mln in 2023

THOMSON REUTERS
·
12 Mar

MaxCyte Inc - Sees 2025 Core Revenue to Grow 8% to 15% Compared to 2024

THOMSON REUTERS
·
12 Mar

MaxCyte Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
12 Mar

MaxCyte’s Strategic Expansion and Financial Resilience Drive Buy Rating

TIPRANKS
·
12 Mar

MaxCyte reports Q4 EPS (10c), consensus (12c)

TIPRANKS
·
12 Mar

MaxCyte sees FY25 core business revenue up 8%-15%

TIPRANKS
·
12 Mar

MaxCyte Q4 2024 GAAP EPS $(0.10) Beats $(0.12) Estimate, Sales $8.693M Beat $7.993M Estimate

Benzinga
·
12 Mar

MaxCyte Inc Qtrly Loss per Share $0.10

THOMSON REUTERS
·
12 Mar

MaxCyte Inc Q4 Shr View $-0.12 -- Lseg Ibes Data

THOMSON REUTERS
·
12 Mar

MaxCyte Inc Outlook Core Revenue Is Expected to Grow 8% to 15% in 2025 Compared to 2024

THOMSON REUTERS
·
12 Mar

BRIEF-MaxCyte Q4 Revenue USD 8.7 Million Vs. IBES Estimate USD 7.93 Million

Reuters
·
12 Mar

MaxCyte Q4 Gross Profit USD 6.4 Million

THOMSON REUTERS
·
12 Mar

MaxCyte Q4 Adjusted Ebitda USD -11.8 Million

THOMSON REUTERS
·
12 Mar

MaxCyte Inc expected to post a loss of 12 cents a share - Earnings Preview

Reuters
·
08 Mar

MaxCyte Expands Stock Capital with New Issuance

TIPRANKS
·
04 Mar